As with all clinical trials, the MHRA’s top priority is the safety and wellbeing of the trial participants. This content is
Use the original NHS England report for the full story and treat this page as a linked clinical update rather than a republished article.
ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.